KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) EPS (Basic) (2016 - 2025)

Cme (CME) has disclosed EPS (Basic) for 17 consecutive years, with $3.25 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 35.42% to $3.25 in Q4 2025 year-over-year; TTM through Dec 2025 was $11.18, a 15.38% increase, with the full-year FY2025 number at $11.18, up 15.38% from a year prior.
  • EPS (Basic) was $3.25 for Q4 2025 at Cme, up from $2.49 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $3.25 in Q4 2025 to a low of $1.43 in Q2 2021.
  • A 5-year average of $2.22 and a median of $2.3 in 2024 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): surged 125.22% in 2021, then fell 27.8% in 2022.
  • Cme's EPS (Basic) stood at $1.68 in 2021, then rose by 4.76% to $1.76 in 2022, then grew by 27.27% to $2.24 in 2023, then grew by 7.14% to $2.4 in 2024, then skyrocketed by 35.42% to $3.25 in 2025.
  • Per Business Quant, the three most recent readings for CME's EPS (Basic) are $3.25 (Q4 2025), $2.49 (Q3 2025), and $2.81 (Q2 2025).